EXTH-47. DEVELOPMENT OF NANOFIBER-BASED CONTROLLED LOCAL DRUG DELIVERY AS A NOVEL ADJUVANT MODALITY FOR TREATMENT OF GLIOBLASTOMA

There are only two chemotherapeutic agents that are approved by US Food and Drug Administration (FDA) for treatment of newly diagnosed glioblastoma. Gliadel wafer implantation was approved in 2003 as it improved survival in newly diagnosed glioblastoma patients. However, Gliadel wafer use is current...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Majd, Nazanin, Han, Dawewoo, Sasaki, Mika, Yoshino, Hirofumi, Satoshi, Kofuji, Chaudhary, Rekha, Warnick, Ronald, Steckl, Andrew, Sasaki, Atsuo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691996/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.339
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge